Search Results
Update from ESMO 2024: Immunotherapy (IO) for HCC
The use of Immunotherapy in unresectable Hepatocellular Carcinoma (HCC)
GI Cancer ESMO 2024 Highlights: Key Studies Discussed LEAP-012, KEYNOTE-811, POD1UM-303, NICHE-2
Advances and challenges in treatments for hepatocellular carcinoma
ESMO 2024 - Day 1
ESMO 2024: Upper GI cancer update
ESMO 2024: Update on BRAF-altered lung cancer data
Niche-3, CABINET, and Other GI Oncology Updates From ESMO 2024
Highlights: HCC podcast series part 2: 2nd line treatment in advanced HCC and when to switch
2nd line treatment in advanced HCC and when to switch
Advances in first-line TKIs for advanced hepatocellular carcinoma
Identifying beneficial subgroups for immunotherapy in BTC using AI tools
